LevitasBio Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 17
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $19M
Latest Deal Amount
  • Investors
  • 3

LevitasBio General Information

Description

Developer of a platform designed to purify cells and nuclei in minutes without any markers or modifications. The company's platform delivers simple, label-free cell separation in a fast, reliable, and gentle workflow to prepare your samples for better results, enabling researchers to levitate sample of interest to focus on the cells that matter - regardless of starting cell number, viability, or purity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Biotechnology
Primary Office
  • 1455 Adams Drive
  • Menlo Park, CA 94025
  • United States

LevitasBio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LevitasBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 13-Jan-2021 $19M 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 08-Apr-2019 Cancelled Generating Revenue
1. Early Stage VC (Series A) 03-Aug-2017 $8M $8M 000.00 Completed Generating Revenue
To view LevitasBio’s complete valuation and funding history, request access »

LevitasBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B-1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 8,166,599 $0.000010 $0.08 $0.98 $0.98 1x $0.98 23.76%
To view LevitasBio’s complete cap table history, request access »

LevitasBio Executive Team (6)

Name Title Board Seat Contact Info
Martin Pieprzyk Chief Executive Officer & Board Member
Paul Steinberg Chief Commercial Officer
Lars Steinmetz Scientific Co-Founder & Board Member
Utkan Demirci Scientific Co-Founder & Board Member
Gozde Durmus Ph.D Scientific Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

LevitasBio Board Members (6)

Name Representing Role Since
Lars Steinmetz LevitasBio Scientific Co-Founder & Board Member 000 0000
Martin Pieprzyk LevitasBio Chief Executive Officer & Board Member 000 0000
Utkan Demirci LevitasBio Scientific Co-Founder & Board Member 000 0000
Victor Tong Self Board Member 000 0000
Xiangmin Cui Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

LevitasBio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LevitasBio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Wuhan Thalys Medical Technology Corporation Minority 000 0000 000000 0
Decheng Capital Venture Capital Minority 000 0000 000000 0
StartX (US) Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view LevitasBio’s complete investors history, request access »